News | FDA | July 02, 2024

FDA Issues Left Ventricular Assist System Monitor Correction: Abbott Issues Correction for HeartMate LVAS System Monitor due to Screen Issues that May Cause Unintentional Pump Stop

This recall involves correcting devices and does not involve removing them from where they are used or sold

Globally approved maximum diameter expansion aims to provide new options in larger diameter and tapered vessels

July 2, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott has issued a correction for its HeartMate LVAS System Monitor due to screen issues that may cause unintentional pump stop. This recall involves correcting devices and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without correction.

Affected Product

Product Names: Thoratec HeartMate System Monitor

Unique Device Identifier (UDI-DI): 00813024010142, 00813024010852

Model Numbers: See full list of affected devices below.

Lot/Serial Numbers: All serial numbers

What to Do

The affected devices are only used by clinicians in a clinical setting such as in an operating room or clinic.

For clinicians

All HeartMate System Monitors may potentially display screen issues.

  • Restart the System Monitor unit before connecting to the patient controller if:
    • The unit has been running for a long period of time, or
    • If screen issues are observed
  • To restart, turn off and then turn on using the On/Off Switch located on the back of the System Monitor. Full restart takes approximately 10 seconds.
    • LVAD settings will remain the same if the unit is restarted while connected to the patient’s controller.
  • Check all cables and connections are secure and undamaged if screen display issues continue after System Monitor restart.
  • Use a different System Monitor if screen issues continue.

In case of pump stop:

If the "Stop Pump" button is inadvertently pressed due to these display issues, the pump will stop for a moment and restart unless the pump stop button is pressed longer than ten seconds. In that case, the pump will stop and the controller will alarm "Pump Off Alarm."

  • Press any button on the controller to attempt pump restart and resolve "Pump Off Alarm," as directed in the Instructions for Use.

On May 8, 2024, Abbott Medical sent all affected customers an Urgent Medical Device Correction letter that included the clinician actions listed above as well as the following additional details and actions:

  • Restarting the System Monitor should resolve the display issues in most cases.
  • Distribute the notice to those who need to be aware within the institution and forward to any institution where potentially affected devices have been transferred.
  • Complete and return the acknowledgement form attached to the letter by email to MCSHMNotices@Abbott.com.

Reason for Correction

Abbott Medical is recalling the HeartMate System Monitor, part of HeartMate LVAS, due to atypical behavior of the System Monitor screen (screen issues). The screen issues include screen freezing, overlapping buttons or screens, unresponsive buttons, distorted text or graphics, and wrong or missing information on the display. These issues can cause a clinician user to inadvertently change pump settings or press the pump stop button.

The use of affected product may cause serious adverse health consequences, including decrease in blood pressure and inadequate flow of blood (hemodynamic compromise) caused by a pump stop. This can lead to stroke, irreversible brain damage, heart or organ failure, and death.

There have been 14 reported injuries. There have been no reports of death.

Device Use

The HeartMate System Monitor is one part of a HeartMate Left Ventricular Assist System (LVAS). The System Monitor is used in the operating room or during clinic visits to:

Monitor system operation closely during LVAD implant

  • Display information about system performance, including current operating mode, pump flow, pump speed, and overall operational status
  • Program system parameters such as pump speed
  • Assess and track alarm conditions
  • View and save performance data
  • Record data at specific intervals to download for review and analysis

An LVAS is used to help the heart pump blood when it is not able to do so effectively on its own. It can be used while waiting for a heart transplant, to help the heart recover, or as a permanent solution when a transplant isn't an option.

Contact Information

Customers in the U.S. with questions about this recall should contact their local firm representative or Abbott Medical Technical Support at 1-800-456-1477.

Full List of Affected Devices

UDI-DI

00813024010142

00813024010852

Model Numbers

1286

L1286

1286A

L1286A

1286A-US

L1286A-US

1286C

L1286C

L1386

1286A-CAN

1286INT

L1286INT

Additional FDA Resources

Additional Company Resources

Unique Device Identifier (UDI)

The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly.

How do I recognize a UDI on a label?

Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

For more information: www.fda.gov


Related Content

News | FDA

July 7, 2025 — Boston Scientific Corp. has received U.S. Food and Drug Administration (FDA) approval to expand the ...

Home July 08, 2025
Home
News | FDA

June 12, 2025 — Viz.ai recently announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for ...

Home June 12, 2025
Home
News | FDA

Nov, 4, 2024 – R3 Vascular Inc. has announced that the U.S. Food and Drug Administration (FDA) granted investigational ...

Home November 07, 2024
Home
News | FDA

July 29, 2024 — CorVascular, a leading producer of peripheral arterial disease (PAD) / peripheral vascular disease (PVD) ...

Home July 29, 2024
Home
News | FDA

June 18, 2024 — Elixir Medical has announced the company’s novel bioadaptive implant, DynamX Sirolimus-Eluting Coronary ...

Home June 18, 2024
Home
News | FDA

June 17, 2024 — Elutia Inc., a pioneer in drug-eluting biomatrix products, today announced that its Antibiotic-Eluting ...

Home June 17, 2024
Home
News | FDA

June 13, 2024 — Xeltis, a leading developer of transformative implants that enable the natural creation of living and ...

Home June 13, 2024
Home
News | FDA

June 3, 2024 — Heuron, a specialized medical AI startup focused on brain and neurological disorders based in South Korea ...

Home June 03, 2024
Home
News | FDA

May 17, 2024 — Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has ...

Home May 17, 2024
Home
News | FDA

May 15, 2024 — The U.S. Food and Drug Administration (FDA) announced that Abbott is recalling the HeartMate 3 LVAS by ...

Home May 15, 2024
Home
Subscribe Now